Research Opportunity: DNA-Protein Epigenetic Chemistry Engineering (D-PECHE)

SOL #: DARPA-SN-26-67Special Notice

Overview

Buyer

DEPT OF DEFENSE
Defense Advanced Research Projects Agency (Darpa)
DEF ADVANCED RESEARCH PROJECTS AGCY
ARLINGTON, VA, 222032114, United States

Place of Performance

Place of performance not available

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

National Defense R&D Services; Department Of Defense Military; Basic Research (AC11)

Set Aside

No set aside specified

Timeline

1
Posted
May 6, 2026
2
Action Date
Jun 24, 2026, 4:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals for the DNA-Protein Epigenetic Chemistry Engineering (D-PECHE) research opportunity. This Special Notice seeks proof-of-concept for novel mechanisms to write and erase epigenetic base modifications in DNA, aiming to control DNA-protein interactions and study rare epigenetic modifications. Abstracts are due May 27, 2026.

Scope of Work

DARPA is looking for research that demonstrates novel technologies to modify nucleic acids in vitro. Key areas include:

  • Developing novel mechanisms for writing or erasing targeted DNA base modifications.
  • Demonstrating the ability to use these mechanisms to modify the epigenome of living cells.
  • Developing methods to detect the presence of targeted base modifications.
  • Focusing on "new-to-nature" base modifications, distinct from established ones like DNA methylation.
  • All research must be conducted as unclassified fundamental research.

Contract & Timeline

  • Type: Special Notice, leading to awards under Other Transactions for Research (OT-R).
  • Duration: The period of performance for the initial study is 4 months.
  • Set-Aside: None specified.
  • Abstract Due: May 27, 2026.
  • Published: May 6, 2026.
  • DARPA intends to make multiple awards.

Submission & Evaluation

  • Abstracts: Limited to 2 pages (excluding title page and references). Late submissions may not be evaluated.
  • Evaluation Criteria: Overall Scientific and Technical Merit; Potential Contribution and Relevance to the DARPA Mission; and Cost and Schedule Realism.
  • Selected proposers will be invited to submit an Oral Proposal Package (OPP) and participate in a virtual oral presentation, approximately 4 weeks after invitation.

Additional Notes

This Special Notice is released under the DARPA BTO Office Wide Broad Agency Announcement (BAA), HR001126S0003. Research involving human subjects or animal subjects is explicitly out of scope, as is research that duplicates work under other DoD programs.

People

Points of Contact

Dr. Aric Lu, DARPA/BTOPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Special Notice
Posted: May 6, 2026
Research Opportunity: DNA-Protein Epigenetic Chemistry Engineering (D-PECHE) | GovScope